EP3490582
Samsetningar til notkunar við meðhöndlun á beinmergstrefjun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.7.2017EP published:
12.6.2024EP application number:
17835212.6
EP translation filed:
29.7.2024Grant published:
15.9.2024EPO information:
European Patent Register
Max expiry date:
25.7.2037Expiry date:
25.7.2026Next due date:
31.7.2026
Title in English:
COMPOSITIONS FOR USE IN TREATING MYELOFIBROSISLanguage of the patent:
English
Timeline
Today
26.7.2017EP application
12.6.2024EP Publication
29.7.2024Translation submitted
15.9.2024Registration published
25.7.2026Expires
Owner
Name:
Acceleron Pharma Inc.Address:
128 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
KUMAR, RavindraAddress:
Acton, MA 01720, US
Name:
VENKATA SAI RAJASEKHAR SURAGANI, NagaAddress:
Wrentham, MA 02093, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662367289 PDate:
27.7.2016Country:
US
Classification
Categories:
A61K 38/17, A61K 47/68, A61P 7/00, A61P 7/06, A61K 31/519, C07K 14/71, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 30.7.2024
Expires: 25.7.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.7.2025
Expires: 25.7.2026
Payer: Árnason Faktor ehf.